Raj Manchandani, MD
Hematology · Leesburg, VANPI 1639387384
Payments from drug & device makers
Across 126 payments — averaging $79.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$6K
- Johnson & Johnson$2K
- Genentech USA, Inc.$230
- Fennec Pharmaceuticals, Inc.$198
- Amgen$183
- GSK$160
- plus $1K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $5,668 |
| Johnson & Johnson(2 entities) | 30 | $2,336 |
| Genentech USA, Inc. | 12 | $230 |
| Fennec Pharmaceuticals, Inc. | 1 | $198 |
| Amgen | 9 | $183 |
| GSK | 1 | $160 |
| Bristol Myers Squibb | 6 | $118 |
| Intuitive Surgical | 1 | $116 |
| Novartis | 5 | $112 |
| Merck | 6 | $93 |
| EMD Serono, Inc. | 3 | $79 |
| Astellas Pharma US Inc | 5 | $73 |
| Seagen Inc. | 3 | $68 |
| Puma Biotechnology, Inc. | 3 | $61 |
| Lilly USA, LLC | 4 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Foundation Medicine, Inc. | 2 | $51 |
| Myriad Genetic Laboratories, Inc. | 2 | $45 |
| Pfizer | 3 | $45 |
| Lexicon Pharmaceuticals, Inc. | 3 | $37 |
| Bayer | 2 | $29 |
| Immunogen, Inc. | 1 | $24 |
| Curonix LLC | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Taiho Oncology, Inc. | 1 | $22 |
| Array Biopharma Inc | 1 | $22 |
| Sanofi | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Clovis Oncology, Inc. | 1 | $12 |
How this compares
$10,031 in reported general payments places this provider in the 65th percentile of 26 hematology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Leesburg
- Laahn FosterCharlottesville$3.1M
- Michael KengCharlottesville$1.7M
- Emily AyersCharlottesville$1.3M
- Indumathy VaradarajanCharlottesville$1.1M
- Hillary MaitlandCharlottesville$445K
- Karen BallenFalls Church$323K
- Ruchi DesaiRichmond$246K
- Stephen MedlinFairfax$102K
- Barbara MacikCharlottesville$90K
- Germame AjeboFairfax$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.